Recent Publications

Recent publications across all six ISSDP Grey Literature Bibliography Categories are held here for one month. They will then be located in specific categories in the main Bibliography to be replaced by more recent research.



Yury Fedotov (UNODC) on Afghanistan, Security Council, 7347th meeting (December 2014)
Video - Statement by Mr. Yury Fedotov, Executive Director of the United Nations Office on Drugs and Crime (UNODC) at the 7347th meeting of the Security Council on the situation in Afghanistan (UNODC)
Overdose Prevention, State by State (December 2014)
Updated Infographic (ONDCP)
Amphetamine Use 2013/14: New Zealand Health Survey (December 2014)
This report presents findings from the 2013/14 New Zealand Health Survey (NZHS) about amphetamine use in the last 12 months (past year) in adults aged 16–64 years of age (Ministry of Health, New Zealand)
ACMD letter to the Home Secretary, December 2014 (December 2014)
The chair of the Advisory Council on the Misuse of Drugs (ACMD) writes to Theresa May about government priorities (Advisory Council on the Misuse of Drugs and Home Office)
Drug policy in Sweden: a repressive approach that increases harm (December 2014)
The central aim of Swedish drug policy is to create a drug-free society. To achieve this aim, the country has adopted a punitive, enforcement-led approach to drugs. It is this approach, some have argued, that is responsible for Sweden’s historically low levels of drug use (TDPF)
Monitoring the Future Results (December 2014)
Survey participants report their drug use behaviors across three time periods: lifetime, past year, and past month (NIDA)
Data co-ordination overview of drug misuse 2013 (December 2014)
Similar to previous years, this data report provides a comprehensive overview of the activity and outcomes that have been achieved by statutory and voluntary agencies working in the area of substance misuse (Health Service Executive, Ireland)
Where is the evidence (December 2014)
Realising the value of grey literature for public policy and practice (Australian Policy Online)
Company narratives in a declining industry (December 2014)
This paper looks at the UK drug treatment field from its emergence in the 1970s to its current position today (Lifeline)
Drug-related deaths and deaths among drug users in Ireland (December 2014)
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning by alcohol and/or other drugs, and deaths among drug users, in the period 2004–2012 (Health Research Board)
Drug misuse and dependence: UK guidelines on clinical management (December 2014)
An expert group considered the consultation responses and discussed whether updating the 2007 clinical guideline would be valuable (Public Health England)
The Impact of Substance Use Disorders on Hospital Use (December 2014)
A better understanding of the impact of substance use disorders (SUDs) on Canada’s hospitals will inform decision making and resource allocation for prevention, education and treatment to improve client care and reduce system costs (CCSA)
Monitoring and Evaluating Scotland’s Alcohol Strategy (December 2014)
Fourth Annual Report (NHS Health Scotland)
Legal Highs, Legal Nightmares (December 2014)
So who?s responsibility is it to regulate, enforce, disrupt or cease the trade in Novel Psychoactive Substances in the UK? (Higher Learning Training Ltd)
Findings of the 2014 ‘Legal High’ National Online Survey (December 2014)
The 2014 Legal High National Online Survey closed on 30th September 2014, and a final report of the findings has now been completed. Slides – Download Survey Findings (Centre for Drug Misuse Research)
Young people’s hospital alcohol pathways (December 2014)
Support pack for A&E departments (Public Health England)
Opium production in the Golden Triangle continues at high levels, threatening regional integration (December 2014)
Opium poppy cultivation in Myanmar and Lao PDR rose to 63,800 hectares (ha) in 2014 compared to 61,200 ha in 2013, increasing for the eighth consecutive year and nearly tripling the amount harvested in 2006, according to the Southeast Asia Opium Survey 2014 (UNODC)
Drug consumption rooms in Europe: Organisational overview (December 2014)
This report provides an overview of the organisation and working methods of drug consumption rooms in Europe (IDPC)
Financing drug policy in Europe in the wake of the economic recession (December 2014)
The economic crisis that Europe experienced in 2008 and later presented a grave challenge to public finances. Countries responded to this by undertaking fiscal consolidation. By examining public expenditure in the areas where most drug-related activities are provided, this report looks at how austerity affected responses to the drugs problem (EMCDDA)
Number of adults in drug and alcohol treatment in England in 2013-14 (December 2014)
Here are 10 things from the data in Public Health England's reports on drug and alcohol treatment in England in 2013-14 (DrugScope)
Comprehensive Harm Reduction Reverses the Trend in New HIV Infections (December 2014)
This summary records the birth and first 20 years of authorized syringe exchange programs (SEPs) in New York State (New York State Department of Health Aids Institute)
The role of social and human capital in recovery from drug and alcohol addiction (December 2014)
This paper reports the results of an evidence review on the role of social and human capital in recovery from drug and alcohol addiction. It has been written for a practitioner audience – to provide stakeholders with key messages from recent research that can be used to inform the decisions they need to make (Health Research Board, Ireland)
Residential rehabilitation: state of the sector in 2014 (December 2014)
Report of a survey of providers and commissioners of residential services (Public Health England)
HRB drug and alcohol evidence review (December 2014)
The role of social and human capital in recovery from drug and alcohol addiction
Gaps in HIV prevention expose Europe to risk of outbreaks (December 2014)
Uneven investment in HIV prevention makes Europe vulnerable (EMCDDA)
Statistics on Drugs Misuse: England, 2014 (December 2014)
This annual statistical report presents information on drug misuse among both adults and children (HSCIC)
Supply-side reduction policy and drug-related harm (December 2014)
The aim of this study was to examine the question of whether seizures of heroin, cocaine or amphetamine type substances (ATS) or supplier arrests for heroin, cocaine or ATS trafficking have any effect on the ED admissions related to or arrests for use and possession of these drugs (BOSCAR)
National Drug Strategy Household Survey detailed report: 2013 (November 2014)
This 2013 National Drug Strategy Household Survey report shows that: - fewer Australians are smoking daily and are smoking less cigarettes; - fewer people are exceeding the lifetime risk and single occasion risk guidelines for alcohol use; - overall illicit drug use has remained stable but some drugs have declined and some have increased; - alcohol continues to be the drug of most concern to the community but an increasing number of people are concerned about meth/amphetamines (AIHW)
Risk assessment of 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-dimethylaminorex, 4,4'-DMAR) (November 2014)
Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently, its control across the EU Member States (EMCDDA)
Risk Assessment Report of a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45) (November 2014)
Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently, its control across the EU Member States (EMCDDA)
Residential treatment for drug use in Europe (November 2014)
The aim of this paper is to provide a Europe-wide overview of the history and availability of residential drug treatment within wider national drug treatment systems
Pregnancy and opioid use: strategies for treatment (November 2014)
Several combinations of substitution medicines and psychosocial approaches are available. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations with cognitive behavioural approaches and contingency management in order to identify the strengths of each medicine and method
Return to the top of the page